November 19 Webcast Auction Featuring Lab Equipment from Migenex
EquipNet is hosting a webcast auction of premium, pre-owned lab equipment. The webcast auction begins at 1:00PM (ET) tomorrow, Thursday, November 19, 2009. Identified as surplus to the ongoing operations at Migenex, the late-model lab equipment is available at a significant cost savings over buying the equivalent, new items directly from the manufacturer.
Canton, MA (PRWEB) November 18, 2009 -- EquipNet is hosting a webcast auction of premium, pre-owned lab equipment. The webcast auction begins at 1:00PM (ET) tomorrow, Thursday, November 19, 2009. Identified as surplus to the ongoing operations at Migenex, the late-model lab equipment is available at a significant cost savings over buying the equivalent, new items directly from the manufacturer.
Currently located in Vancouver, British Columbia, Canada, the auction lot includes a variety of lab equipment, including:
| | - Beckman Allegra X12R Centrifuge
- Beckman System Gold Analytical
- MBI 581 Fraction Collector SF-2120
- Liquid Handling System Biomek 2000
- MBI 940 SpectraMax M5E
- BioCad 700E
- Steris SV 120 Autoclave
|
To view an entire auction catalog and/or register for tomorrow's event, visit: http://bidspotter.com/forms/imagegallery.php?gallery=8645
The EquipNet MarketPlace™ at www.EquipNet.com is the world's largest online venue for buying and selling pre-owned lab equipment, making it the destination of choice for both small and large biotech and pharmaceutical firms looking to save time and money.
"Although we hear that the economy is in recovery, companies are still looking for ways to save money and work smart," explains Dennis Higgins, EquipNet's Director of Biotech Sales. "It makes good business sense to purchase pre-owned lab equipment and save a bundle off the price of buying new items."
About EquipNet
EquipNet is a leading provider of proactive asset management solutions and services to leading corporations in the biotech, pharmaceutical, chemical, and consumer packaged goods industries, such as Merck, GlaxoSmithKline, AstraZeneca, Unilever and many others. EquipNet's vision is to revolutionize the way companies manage their surplus assets by maximizing financial returns and minimizing the risks associated with idle capital assets. For more information, please visit: http://www.EquipNet.com.
###
|
